Loading...
•
Jun 30, 2023
Exponent Q2 2023 Earnings Report
Exponent reported solid second quarter results with revenue growth and expanded earnings per diluted share.
Key Takeaways
Exponent's Q2 2023 showed a 9.7% increase in revenues before reimbursements, reaching $129.7 million, and earnings per diluted share increased to $0.50. Growth was driven by demand for reactive offerings and increased demand in the chemicals and life sciences sectors.
Total revenues increased by 7.6% to $140.2 million compared to the second quarter of 2022.
Revenues before reimbursements increased by 9.7% to $129.7 million compared to the second quarter of 2022.
Net income was $25.7 million, or $0.50 per diluted share.
The company's engineering and other scientific segment represented 83% of the Company’s revenues before reimbursements.
Exponent
Exponent
Exponent Revenue by Segment
Revenue by Segment
Engineering & Other Scientific Revenue
CapyFin.comEnvironmental & Health Revenue
CapyFin.com Forward Guidance
Exponent is maintaining its revenue and margin guidance for the full 2023 fiscal year.
Revenue & Expenses
Visualization of income flow from segment revenue to net income